These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 16988530

  • 1. Off-label promotion.
    Somberg J.
    Am J Ther; 2006; 13(5):387. PubMed ID: 16988530
    [No Abstract] [Full Text] [Related]

  • 2. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK.
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract] [Full Text] [Related]

  • 3. PLIVA v. Mensing: generic consumers' unfortunate hand.
    Lee SB.
    Yale J Health Policy Law Ethics; 2012; 12(2):209-63. PubMed ID: 23175916
    [No Abstract] [Full Text] [Related]

  • 4. Sandoz sues FDA over delay in first biogeneric approval.
    Fox JL.
    Nat Biotechnol; 2005 Nov; 23(11):1327-8. PubMed ID: 16273046
    [No Abstract] [Full Text] [Related]

  • 5. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J.
    New Yorker; 2006 Dec 18; ():40-7. PubMed ID: 17176539
    [No Abstract] [Full Text] [Related]

  • 6. Pharma allowed to make own genetics.
    Owens J.
    Nat Rev Drug Discov; 2005 Jul 18; 4(7):530. PubMed ID: 16075483
    [No Abstract] [Full Text] [Related]

  • 7. Raising the bar for market authorisation of new drugs.
    Naci H, Cylus J, Vandoros S, Sato A, Perampaladas K.
    BMJ; 2012 Aug 07; 345():e4261. PubMed ID: 22872693
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
    Zelenay JL.
    Food Drug Law J; 2005 Aug 07; 60(2):261-338. PubMed ID: 16094773
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The FDA and "privatization"--the drug approval process.
    Rutherford EM.
    Food Drug Law J; 1995 Aug 07; 50 Spec():203-25. PubMed ID: 10343044
    [No Abstract] [Full Text] [Related]

  • 15. The FDA's critical path initiative: a brief introduction.
    Coons SJ.
    Clin Ther; 2009 Nov 07; 31(11):2572-3. PubMed ID: 20110002
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Regulatory watch: impact of PDUFA on regulatory decision-making.
    Hay M.
    Nat Rev Drug Discov; 2010 Aug 07; 9(8):585. PubMed ID: 20671755
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.